FDA.reportPublic FDA data

No7 Laboratories Acne Treatment

Manufacturer
BCM Ltd | The Boots Company PLC
Effective date
2020-11-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:33:25

Label at a glance#

ProductNo7 Laboratories Acne Treatment
Active ingredientSALICYLIC ACID
Label structure11 sections

Indications and uses

Uses For the treatment of acne

Dosage and administration

Directions Clean the skin thoroughly before applying the product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Active ingredient Purpose

Salicylic acid Acne Treatment

Dosage

DOSAGE & ADMINISTRATION SECTION

2%

Uses

OTC - PURPOSE SECTION

Uses

For the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

skin irritation and dryess is more likely to occur if you use anohter topical acne medication at the same time. If irritation occurs, only use on topical acne medication at a time.

Avoid contact with eyes.

If contact occurs, flush thoroughly with water.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

INDICATIONS & USAGE SECTION

Directions

Clean the skin thoroughly before applying the product.

Cover the entire affected area with a thin layer one to three times daily.

Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.

If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua (Water), Kaolin, Octyldodecanol, Alcohol denat., Cetearyl alcohol, Butylene glycol, Polyacrylamide, Steareth-21, Polyacrylate crosspolymer-6, C13-14 isoparaffin, Hamamelis virginiana (Witch hazel) water, Potassium hydroxide, Steareth-2, betaine, Dimethicon, Ammonium glycyrrhizate, Alpha-glucan oligosaccharide, Phenoxyethanol, Laureth-7, Caprylyl glycol, Bisabolol, Xanthan gum, Alcohol, Exylhexylglycerin, Tetrasodium EDTA, T-butyl alcohol, Fructose, Glucose, CI 14700 (Red 4), CI 42090 (Blue 1).

INFORMATION FOR PATIENTS SECTION

Made in the UK

The Boots Company PLC

Nottingham England NG2 3AA

Dist. in the USA by Boots Retail USA Inc.

New York NY 10005

Made in the UK

www.no7beauty.com

Questions

OTC - QUESTIONS SECTION

USA: Questions? 1-866-752-6687

Description 

DESCRIPTION SECTION

No7

LABORATORIES

CLINICALLY PROVEN

CLINICALLY PROVEN

ACNE TREATMENT

2% Salicylic Acid

Reduce the appearance of acne & blemishes overnight

Dermatologist approved

2% SALICYLIC ACID

+ PRE-BIOTIC TECHNOLOGY

50 ml e 1.69 US Fl. Oz.

No7 Laboratories Acne Treatment is clinically proven to receal healthier and clearer looking skin. Dermatologist approved this medicated 2% Salicylic Acid treatment visibly reduces the appearance of acne overnight. With pre-biotic technology, feed your skin for a nourished, blanaced and health-looking complexion.

- Reduces the apperance of acne, blemishes & breakouts overnight

- Renews skin's surface to clear pores, helping to prevent new blemishes forming

- Excess oil is reduced for shine-free skin

- Restores balance to troubled skin

POWERED BY:

2% SALICYLIC ACID

+ PRE-BIOTIC TECHNOLOGY

In 1 week women agreed their skin's appearance had been transformed, and after 4 weeks saw their clearest complexion in years.

Fragrance free and suitable for sensitive skin.

For best results: In the evening after cleansing skin apply a thin layer of the product to troublesome area. Leav on overnight and rinse away in the morning. Use 2-3 times a week.

Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cartonN7LAT_1N7LAT_1 N7LAT_2N7LAT_2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
251577salicylic acid 2 % Topical SolutionPSN1
251577salicylic acid 20 MG/ML Topical SolutionSCD1
251577salicylic acid 2 % Topical SolutionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d1c9d1af-bddd-448d-86f7-69052b7d5b47Product name120220627
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11489-176-012025-01-30C16284748780-12cef2736-9030-d83d-e063-dadaa90ab31fNo7 Laboratories Acne Treatment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11489-176-01No7 Laboratories Acne Treatment1 in 1 CARTONLIQUID11
11489-176-01No7 Laboratories Acne Treatment50 g in 1 TUBELIQUID501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11489-176NO7 LABORATORIES ACNE TREATMENT (SALICYLIC ACID) LIQUID [BCM LTD]1Legacy NDC, 2 package rows20201112_fee4eefc-010b-4576-90b7-04e17504ba28.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 29 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11489-17611489-176-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
WATER059QF0KO0RIACT
KAOLIN24H4NWX5COIACT
OCTYLDODECANOL461N1O614YIACT
ALCOHOL3K9958V90MIACT
CETOSTEARYL ALCOHOL2DMT128M1SIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
POLYACRYLAMIDE (10000 MW)E2KR9C9V2IIACT
STEARETH-2153J3F32P58IACT
TRIMETHYLOLPROPANE TRIACRYLATE4B67KGL96SIACT
C13-14 ISOPARAFFINE4F12ROE70IACT
HAMAMELIS VIRGINIANA LEAF WATER8FP93ED6H2IACT
POTASSIUM HYDROXIDEWZH3C48M4TIACT
STEARETH-2V56DFE46J5IACT
BETAINE3SCV180C9WIACT
DIMETHICONE92RU3N3Y1OIACT
AMMONIUM GLYCYRRHIZATE3VRD35U26CIACT
.ALPHA.-GLUCAN OLIGOSACCHARIDES95658MI3WIACT
PHENOXYETHANOLHIE492ZZ3TIACT
LAURETH-7Z95S6G8201IACT
CAPRYLYL GLYCOL00YIU5438UIACT
BISABOLOL OXIDE A16AE65F94YIACT
XANTHAN GUMTTV12P4NEEIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
ETIDRONATE TETRASODIUMCZZ9T1T1X4IACT
TERT-BUTYL ALCOHOLMD83SFE959IACT
FRUCTOSE6YSS42VSEVIACT
DEXTROSEIY9XDZ35W2IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a09231a-44bc-4242-b49f-7e476c4b98d3fee4eefc-010b-4576-90b7-04e17504ba282020-11-04WarningsExact identifier
spl id: 4a09231a-44bc-4242-b49f-7e476c4b98d3
spl set id: fee4eefc-010b-4576-90b7-04e17504ba28

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.